David Mitchell, PharmD, MBA, UC Davis, shares how collaboration between health systems and manufacturers is transforming patient access and outcomes for rare disease treatments. In the second half of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback